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Abstract. The preparation of enantiomerically pure compounds 
(EPC) is a continuous social demand due to the clinical advantages 
that enantiopure drugs offer over the racemic forms. Here, the best 
well-established synthetic strategies to access to single-enantiomer 
compounds are briefly described and compared. In particular, the 
enantioselective catalysis is introduced paying special attention to 
the organocatalysis, an emerging and fruitful area in the EPC-
synthesis. Of particular interest is the use of small organic 
molecules as catalysts in cascade reactions. Organocascade 
reactions involve the formation of several chemical bonds and 
often generate stereogenic centers with excellent stereoselectivity. 
Such one-pot reactions avoid time-consuming and costly step-by-
step processes and are environmentally friendly as they occur in 
the absence of metals. Additionally, the chemical waste of the 
organocatytic cascade reactions is drastically reduced since the 
intermediates are not isolated and purified. 
 
Introduction 
 
 In the pharmaceutical field, stereochemistry is placed in an extremely 
relevant position. The tridimensional structure of a compound is very 
important  when  interacting  with  a chiral     medium  as the  human  body,  the      
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biological effect directly depending on the stereochemistry of the exogenous 
compound and the receptor. Thus, a single-enantiomer drug can be 
pharmacologically interesting whereas its mirror image can be inactive or 
display a different desirable or non-desirable activity. Therefore, the 
administration of enantiopure drugs brings benefits in terms of improved 
efficacy, more predictable pharmacokinetics and reduced toxicity [1]. These 
advantages forced pharmaceutical companies [2] and health authorities [3] to 
place stereochemically pure substances in a privileged position. 
Consequently, it is not strange that 7 out of the top 10 most selling-drugs 
worldwide in 2010 are commercialized as enantiopure forms. Among them, 
the top three positions are for Nexium® (esomeprazole), Lipitor® 
(atorvastatin), and Plavix® (clopidogrel), with a whole invoicing of 15 billion 
dollars [4].  
 The large demand of enantiopure products has broken out the progress of 
the asymmetric synthesis, considered in the last years as one of the most 
important areas of research in both industry and academia. Nowadays, the 
number of synthetic methods available for the preparation of chiral molecules 
has permitted to efficiently gain access to a myriad of enantiomerically pure 
compounds. 
 
1. Strategies for the elaboration of enantiopure compounds 
 
 In 1980 Prof. Seebach [5] introduced the term "EPC-synthesis" (synthesis 
of enantiomerically pure compounds) to include all the processes for the 
preparation of chiral enantiopure compounds. The three main synthetic 
approaches in EPC-synthesis are listed below (Fig. 1) [6]: 
 
? Resolution of racemates. 
? Synthetic transformations from an enantiomerically pure starting 
compound. In the particular case of an easily available natural 
compound it is called synthesis from the chiral pool. 
? Stereoselective reactions that involve an enantiopure reagent as a 
source of chirality, in stoichiometric (auxiliary) or catalytic amounts, 
which is not included in the final product.  
 
 Next, the three main strategies to obtain enantiopure compounds are 
outlined.   
 The first optical resolution of a racemic mixture was performed by Prof. 
Pasteur in 1848, who was able to manually separate the two kinds of 
hemihedral crystals of racemic tartaric acid salts [7]. This fact represented the 
discovery    of the molecular  chirality and of the spontaneous resolution [8].  In 
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Figure 1. Strategies for the synthesis of enantiopure compounds. 
 
spite of the simplicity of this separation technique it is limited to 
conglomerates, since both enantiomers of the substance deposit in equal 
quantities as enantiomorphous crystals [9]. It is worthy of note that only 
between 5 to 10% of the total chiral organic solids reveals as conglomerates. 
Notably, the vast majority of resolutions involve the conversion of a 
racemate, by treatment with an enantiomer of a chiral substance, into 
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diastereomeric salts (Eq.1, Fig. 1). The different solubility properties of the 
diastereomeric salts allow the separation of both products and the subsequent 
treatment with a base or an acid give access to both enantiomers.  
 Apart from the aforementioned resolution process based on physical 
properties like solubility, there are other resolution processes as the kinetic 
resolution. The kinetic resolution relies on the unequal reaction rates of the 
enantiomers with a chiral nonracemic reagent (Eq. 2, Fig. 1). In that case, the 
reaction rates should be different enough to recover the less reactive or non-
reactive enantiomer. The maximum theoretical yield for a kinetic resolution 
is 50% for each enantiomer and one of them is chemically modified. Of 
particular interest is the dynamic kinetic resolution that permits the total 
conversion of a racemic mixture into a single enantiopure product (Eq. 3,  
Fig. 1). This strategy involves a standard kinetic resolution and an in situ 
racemization process of the less reactive enantiomer (unchanged enantiomer), 
which must be a labile chiral substrate for the easy conversion into the 
racemic mixture again [10].  
 In the chiral pool synthesis the chiral source is a natural enantiopure 
compound that will remain included in the structure of the final product (Eq. 4, 
Fig. 1). This methodology is therefore more useful when the desired final product 
and the chiral compound used are structurally similar. The chiral pool arsenal is 
integrated by carbohydrates, amino acids, hydroxy acids and terpenes.  
 The stereoselective synthesis from prochiral substrates is a potent tool 
that allows the preparation of a broad variety of enantiopure compounds. This 
methodology involves chemical reactions that introduce one or more 
elements of chirality in a substrate molecule producing stereoisomeric 
products (enantio- or diastereoisomers) in unequal amounts [11]. A chiral 
auxiliary or a catalyst is responsible for the asymmetric induction. 
 The use of auxiliaries is based on the temporarily incorporation of a 
chiral moiety in a prochiral substrate (Eq. 5, Fig. 1) generating new elements 
of chirality selectively. The process involves: 1) the introduction of the 
auxiliary; 2) high diastereoselectivity in the process of generation of the new 
elements of chirality, 3) separation of the formed diastereoisomers and finally 
4) recovery of the chiral auxiliary. As chiral auxiliaries are required in 
stoichiometric quantities, their preparation has to be easy and inexpensive. 
 Nowadays, different well-known chiral auxiliaries allow to selectively 
perform a great number of reactions [12]. Among them the Evans' 
oxazolidinones [13] or the Oppolzer's sultames [14] constitute robust 
examples. Remarkably, the use of chiral amino alcohols pioneered by A. I. 
Meyers [15], and extended for other research groups [16], played an important 
role as chiral auxiliary strategy and nitrogen source for the efficient synthesis 
of alkaloids and nitrogen-containing bioactive compounds. 
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 Chiral auxiliaries become very popular 30 years ago due to their 
efficiency in the generation of stereoselectivity, affording 100% pure 
enantiomers after the separation of the diastereoisomers. However, the need 
for using stoichiometric quantities of the chiral auxiliary and the 
disadvantage of requiring two additional synthetic steps, introduction and 
removal of the auxiliary, prompted synthetic chemists to divert their attention 
to the asymmetric or enantioselective catalysis. 
 In the enantioselective catalysis the chiral information is transferred by 
an enantiopure catalyst, which means that substoichiometric quantities of a 
chiral molecule activate the substrate in a reversible manner to accelerate the 
reaction (Eq. 6, Fig. 1). As the interaction between the catalyst and the 
substrate is reversible the catalyst is not consumed during the process and can 
be introduced in a new catalytic cycle. The atom economy of the process is 
optimal, minimizing the waste generated [17]. An additional advantage of this 
methodology is the multiplication of the chirality [18], since stoichiometric 
quantities of enantioenriched product are obtained from substoichiometric 
quantities of catalyst.  
 In contrast to the use of chiral auxiliaries that affords enantiopure compounds 
through diasteromeric intermediates, asymmetric catalysis furnishes directly 
enantiomers from prochiral compounds allowing the preparation of a broad 
variety of chiral compounds with high enantiomeric excess.  
 A relevant datum of the importance of asymmetric catalysis in Chemistry 
is that Profs. W. S. Knowles, R. Noyori and K. B. Sharpless were awarded 
with the Nobel Prize in 2001 due to their research on the field (Fig. 2).  
 Enantioselective catalysis can be divided in three main areas, 
biocatalysis, organometallic catalysis and organocatalysis, depending on the 
nature of the chiral catalysts employed. 
 In the biocatalysis an enzyme is responsible for the acceleration of the 
process [19]. Due to their complex tridimensional structure of L-amino acids, 
the biocatalysts are involved in highly chemo-, regio-, diastereo- and 
enantioselective processes. Moreover, these reactions are carried out under 
mild conditions to avoid side products and the processes are environmentally 
harmless.   
 The organometallic catalysis is responsible for the most part of the 
enantioselective catalysis published in the last years [20]. The success of this 
area is mostly due to the particular affinity of metals to complex with 
functional groups and to the structurally well defined metal-organic ligand 
complexes which is translated into an efficient asymmetric induction.  
 An important contribution in the field dates from the seventies when 
Prof. W. S. Knowles and co-workers [21] demonstrated that complexes of 
rhodium   and  phosphine ligands  with C2 symmetry catalysed the  addition  of 
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Figure 2. Nobel Prize in Chemistry (2001) shared by W. S. Knowles, R. Noyori and 
K. B. Sharpless. (http://www.nobelprize.org/nobel_prizes/chemistry/laureates/2001/) 
 
hydrogen to one of the faces of a prochiral olefin to generate a stereogenic  
C-H center with high enantioselectivity (Fig. 3). Apart from giving a boost to 
the development of ligands with a C2 symmetry axis, the main application of 
this reaction was the industrial preparation of L-dopa [22]. 
 Nowadays, the organometallic catalysis enjoys an elevate grade of 
development including participation in a great variety of oxidations, 
reductions, insertions to σ bonds, activations of π bonds and reactions 
catalysed by Lewis acids. In spite of this advantage, some organometallic 
complexes are expensive, demanding on strict reaction conditions, and metals 
are toxic which is negative from both the environment and the contamination 
of the final product point of view.  
 
 
 
Figure 3. Enantioselective hydrogenation catalysed by rhodium-DiPAMP complex. 
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 Environmental and health regulations gave strong support to cleaner and 
non-toxic chemical processes avoiding the use of toxic reagents. Chemical 
companies consider that get rid of transition metals in catalytic reactions is 
highly desirable. In fact Nature, our source of inspiration, does not use metals 
for the most part of biocatalytic processes. In this sense, the efforts made for 
the scientific community to get synthetic sequences free of metals have 
driven to the configuration of a new area within the enantioselective 
synthesis: the organocatalysis. 
 The organocatalysis is defined as the acceleration of chemical reactions by 
small organic molecules in the absence of metals [23]. Although the 
organocatalysis is a field that has been incredibly developed in the last decade, 
the use of organic molecules to catalise chemical reactions has been known for 
more than a century [24]. In 1896, Emil Knoevenagel used a secondary amine 
(piperidine) to accelerate the condensations that received his name (Fig. 4) [25].  
 The first example of an asymmetric organocatalysis was described by 
Mackwald in 1904 using the brucine alkaloid in a decarboxylation process 
[26]. In 1912, Bredig and Fiske described the asymmetric addition of HCN to 
benzaldehyde catalysed by cinchona alkaloids [27]. However, those examples 
occurred with a low enantiomeric excess, below 10%. Later on, in 1960 
Pracejus published the organocatalytic methanolysis of a ketene with higher 
enantioselectivity levels (76% ee) [28]. In the seventies a remarkable hit in 
the organocatalysis was achieved when the first asymmetric aldolization 
(Hajos-Parrish-Eder-Sauer-Wiechert reaction) catalysed by L-proline was 
described (Fig. 5) [29].  
 In the following decades (1980-2000), two new fields in the catalysis 
with organic molecules started with the publication of the two first examples 
in the phase transfer catalysis [30] and the activation through hydrogen-
bonding interactions [31].  
 
 
 
Figure 4. Prof. Emil Knoevenagel (1865-1921). Piperidine catalysed the reaction of 
diethyl malonate with benzaldehyde.  
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Figure 5. Hajos-Parrish-Eder-Sauer-Wiechert reaction. 
 
 In 2000, a study carried out by List, Lerner and Barbas III demonstrated 
the ability of small molecules to catalyse reactions that until then were 
promoted by bigger organic molecules or enzymes through similar 
mechanisms [32]. The same year, MacMillan and co-workers developed the 
first highly enantioselective organocatalytic Diels-Alder reaction catalysed by 
a secondary chiral amine, an imidazolidinone [33].  
 This new application and the conceptualization of the word 
"organocatalysis" by MacMillan, represented the revival of the secondary 
amines and other organic molecules as catalysts. The strong support of the 
scientific community to this field was due to the numerous advantages that 
the small molecules represent for catalysis. Some of them are listed below: 
 
? The organocatalysts usually are non-sensitive to the humidity and 
the atmospheric oxygen. This stability makes catalysts easy to 
handle because it is not necessary the use of dry boxes, inert 
atmosphere or anhydrous solvents, improving the reproducibility of 
the results. 
? Nature provides enantiopure compounds that can be used directly as 
organocatalysts. Thus, these molecules are easily available in 
considerable quantities and in both enantiomeric series. 
? The organocatalysts are low or non-toxic substances, respectful with 
the environment. Moreover, they can be easily isolated from the 
reaction mixtures avoiding the contamination of the final product. It 
is noteworthy that the most part of the organocatalytic reactions are 
performed in high concentration or in the absence of solvent 
minimizing the expenses of solvent and the formation of additional 
residues. These properties increase the level of safety and reduce the 
cost of research either in the academic or industrial areas. 
  
 Nowadays, the organocatalysis is a potent synthetic tool situated in a 
privileged position between the two main catalytic strategies (the bio and 
metal catalysis) and complements them. 
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 The interest in catalysis with organic molecules is indicated in the 
increasing number of publications related to this subject in the last decade. 
The number of publications containing the concept of "organocatalysis" rose 
steadily from 2000 to 2007 (Fig. 6) rising to 821 publications in the year 
2010. Prior to 2000 the number of articles containing the indicated keyword 
was almost negligible.  
 
 
 
Figure 6. Number of publications including the term "organocatalysis" in the title or in the 
abstract from the year 2000 (4) to 2010 (821) in the SciFinder Scholar (2007) database. 
 
 This tremendous advance in the organocatalysis has given access to a 
great number of enantiomerically pure compounds with an added value from 
the biological and structural point of view including drugs and natural 
complex products [34]. 
 The development of novel activation methods is responsible for the rapid and 
continuous progress on the organocatalytic area gaining applicability to wide 
organic reactions. In a first level, the different activation methods can be 
classified taking into account if the reversible interaction between the catalyst and 
the substrate is non covalent (1) or covalent (2). The former is also divided 
depending on the implication of ionic pairs or hydrogen bonds. The latter is 
classified into N-heterocycles carbene catalysis or amine catalysis, also known as 
aminocatalysis. The reactive species that is formed when the catalyst interacts 
with the substrate determines the kind of aminocatalysis involved. Next, this 
classification is underlined and the different headings are briefly described. 
 
1. Non covalent interactions: 
 a. Formation of ionic pairs: 
  i. Phase transfer catalysis 
  ii. BrØnsted base catalysis 
 b. Formation of hydrogen bonds 
2. Covalent interactions: 
 a. Catalysis with N-heterocyclic carbenes 
 b. Catalysis with amines (via iminium ion, enamine,   
  dienamine, radical cation or ammonium ion) 
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 The enantioselective phase transfer catalysis (PTC) (1.a.i) is performed in a 
heterogeneous medium and uses quaternary ammonium salts to facilitate the 
migration of the reagent from one phase to the other. The asymmetric induction 
is based in the formation of a chiral ionic pair soluble in the organic phase that 
is where the stereoselective reaction occurs. The most used ammonium salts are 
the cinchona alkaloids derivatives and binaphthylamine derivatives [35]. The 
BrØnsted base catalysis (1.a.ii) [36] is based on the use of a chiral base able to 
deprotonate a (pro)nucleophile (chiral ionic pair) increasing the reactivity in 
front of eletrophiles. The most employed BrØnsted bases as chiral catalysts are 
the cinchona alkaloids and derivatives, due to their availability and their 
catalytic and inductive efficiency. This family of compounds is found in Nature 
as two pseudoenantiomeric forms (Fig. 7) and each of them furnishes one of 
the two possible enantiomers of the reaction product. 
 
 
 
Figure 7. Pseudoenantiomeric cinchona alkaloids. 
 
 Cinchona alkaloids have been considered as one of the most privileged 
chiral inductors in organic synthesis [37]. Different structural features of 
cinchona alkaloids are responsible for the efficient activation and 
transmission of the chiral information to the substrate [38]: 1) the presence of 
a basic nitrogen atom included in a bulky quinuclidine nucleus and a 
secondary alcohol that can activate the substrate establishing hydrogen- 
bonding interactions; and 2) the presence of a quinoline ring that can adopt 
different conformations in the reaction media acting as a "molecular wall" for 
the preferential approach of the reagent. When the basic nitrogen of the 
quinuclidine activates the (pro)nucleophile and the hydroxyl group interacts 
with the electrophile through hydrogen-bonding interactions, cinchona 
alkaloids are considered to be bifunctional catalysts as a double simultaneous 
activation occurs in the process [39]. 
 The formation of hydrogen bonds is very important in biological systems 
and in metabolic terms such interaction between enzymes and substrates 
means the acceleration of a wide variety of reactions. This biological strategy 
of activation is mimicked by different catalysts (1.b) [40]. Among them, 
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phosphoric acids and thioureas stand out due to their efficiency in the 
formation of highly organized transition states, a very important factor for the 
discrimination of the enantiotopic faces of a substrate. 
 In the catalysis through covalent interactions between a catalyst and a 
substrate is highlighted the use of N-heterocyclic carbenes (2.a) [41] and the 
catalysis using amines (2.b) [42]. The aminocatalysis is based on the use of 
amines as catalysts and represents an important part of the organocatalysis. 
There are different activation modes in aminocatalysis that allow to establish 
a classification depending on the reactive species that is generated in the 
interaction between the substrate and the catalyst.  
 In the iminium ion catalysis [43] the reactive species is an iminium salt 
formed by the reversible reaction between a primary or secondary amine 
(catalyst) and a carbonyl compound (substrate). Thus, a lowering in the 
energetic potential of the lowest unoccupied molecular orbital (LUMO) is 
observed facilitating the reaction with nucleophiles. The Knoevenagel 
condensation and the Michael addition are two examples of reaction in which 
this activation strategy has been successfully applied. When the substrate is 
an α,β-unsaturated ketone or aldehyde, the iminium ion catalysis favors the 
β-functionalization of the carbonyl compound (Fig. 8). 
 The catalysis via enamine [44] involves the generation of an enamine that 
results from the tautomerization of an iminium ion intermediate. In that case, 
a primary or secondary amine activates the substrate increasing the energetic 
potential of the highest occupied molecular orbital (HOMO). The HOMO-
raising activation facilitates the reactivity of the α-carbonyl position with 
electrophiles. This strategy has been frequently used in aldol and Mannich 
reactions (Fig. 9). 
 
 
 
Figure 8. Activation via iminium ion (Nu = nucleophile). 
 
 
 
Figure 9. Activation via enamine (E = electrophile). 
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 The catalysis via dienamine, introduced in 2006 by JØrgensen and co-
workers [45], can be considered as a kind of catalysis via enamine and it has 
been used for the functionalization of the γ position of α,β-unsaturated 
aldehydes with electrophiles.  
 In the last years, a new class of catalysis via radical cation has been 
developed [46]. In this case, SOMO (single electron occupied molecular 
orbital) activation is produced allowing the introduction of different 
substituents in the α carbonyl position. This new methodology has expanded 
the field of organocatalysis merging aminocatalysis with radical chemistry. 
 Finally, the catalysis via ammonium ion implies tertiary amines [47] as 
catalysts. The formation of ammonium enolates [48] typically with cinchona 
alkaloids, and the formation of acyl-ammonium with DMAP analogues [49] 
are representative examples. 
 The transmission of the chiral information from the catalyst to the final 
product must be very efficient in order to achieve stereoselective chemical 
processes. In the particular case of the aminocatalysis, the stereoelectronic 
properties of the catalyst (amine) are responsible for the asymmetric 
induction. Thus, the stereocontrol of a reaction can be determined by steric 
factors, electronic factors or a combination of both. Chiral catalysts bearing 
bulky groups can prevent an arbitrary approach of the reagent to the substrate 
forcing an oriented bond formation that avoids the steric hindrance. In an 
opposite way but complementary, catalysts with hydrogen-bond donating 
groups can establish interactions of electronic affinity with hydrogen-bond 
accepting groups present in the reagent, thus facilitating the reaction between 
the two reacting partners in a well-defined manner. 
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Figure 10. Stereoelectronic control of the reaction by the catalyst. 
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 Figure 10 depicts how different substituted chiral pirrolidines (A and B) 
can orientate and control the addition of aldehydes to electrophiles through an 
enamine like intermediate. The presence of bulky substituents in the 
organocatalyst (A) can shield the enamine Re face forcing the electrophile to 
a Si face approach. However, the use of pirrolidines with hydrogen-bond 
donor groups (B) would facilitate the approach of the electrophile 
preferentially for Re face of the enamine. Thus, both strategies would drive to 
opposite enantiomers. 
 
2. Cascade reactions 
 
 Evolution provided living organisms with biosynthetic processes that 
convert efficiently simple molecules into complex molecular systems. One of 
the key features of the biosynthetic routes in Nature is the achievement of 
cascade reactions. As an example, the pharmacologically and structurally 
very interesting diterpene taxol is proposed to be biosynthetically prepared in 
just five steps involving few enzymes [50] (Fig. 11). However, the most 
efficient synthesis of taxol achieved in the laboratory by Wender´s group 
involved 37 steps from verbenone with 0.44% overall yield [51]. 
  
 
 
Figure 11. Proposed biosynthesis of taxol. 
 
 In the laboratory, the preparation of complex chiral molecules requires 
several synthetic steps and involves the isolation and purification of 
intermediates. This operational strategy prevents, in most cases, a low-cost 
fast access to enough quantities of interesting natural products and bioactive 
compounds for the benefit of the community.  
 The attempts to mimic Nature for avoiding these limitations led to the 
development of new one-pot strategies. The one-pot reactions are carried out 
in a simple vessel allowing the formation of various chemical bonds and 
stereogenic centers without the isolation or purification of intermediates. 
Thus, the efficiency of the synthesis increases since the number of synthetic 
steps is reduced. As a consequence, there is a minimum consumption of 
chemicals and a minimization of waste, reducing environmental 
contamination. Therefore, chemical companies concerned about economic 
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and ecological profitability are really interested in one-pot reactions. Merck 
Research Laboratories described an impressive synthetic sequence for the 
preparation of the anti-migraine drug telcagepant (Fig. 12) [52]. A symbiosis 
between one-pot reactions and organocatalysis using Jørgensen's catalyst is 
the key feature of a brilliant synthesis with the isolation of only three 
intermediates and without chromatographic purification. This example 
illustrates the preparation on an industrial scale drug by an environmentally 
friendly process with the high quality standards that the pharmaceutical 
production demands. 
 
 
  
Figure 12. Synthesis of telcagepant potassium salt from 1,2-difluorobenzene by 
Merck Research Laboratories. 
  
 Recently, different terms to describe one-pot processes have been 
considered. Tietze [53] described a domino reaction as the process involving 
two or more sequential bond-forming transformations which take place under 
the same reaction conditions. In a tandem process the transformations occur 
simultaneously sometimes using two or more different catalytic processes 
[54]. However, the term cascade reaction is used to include the above 
mentioned one-pot reactions [55].  
 The advantages and continuous development of this bio-inspired strategy 
has converted cascade reactions in a useful tool for the rapid access to 
molecular complexity [56].  
 The combination of enantioselective catalysis, one of the most efficient 
methods in EPC-synthesis, with cascade reactions is one of the most 
powerful approaches for the preparation of chiral complex molecules, and it 
is known as organocascades or organocatalytic cascades (Fig. 13) [57]. 
 The organocatalytic approach in cascade reactions frequently involves 
only one catalyst that usually interacts with carbonyl substrates. The 
organocascades are based on the easy tautomeric iminium ion-enamine 
conversion and the different reactivity of the resulting tautomers to furnish 
consecutive reactions. The catalysis via iminium ion allows the addition of 
nucleophiles in the β-position of α,β-unsaturated carbonyl compounds. This 
addition generates an enamine-like intermediate that can react with the 
electrophiles present in the reaction media (Fig. 14).  
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Figure 13. Organocatalytic cascades. 
  
 
 
Figure 14. Domino reaction via activation iminium ion-enamine. 
 
 The combination of sequential activations via iminium ion-enamine has 
provided numerous organocatalytic cascade syntheses of enantiomerically 
pure molecules. It is noteworthy the triple cascade reaction via activation 
enamine-iminium-enamine reported by Enders and co-workers for the 
synthesis of pentasubstituted cyclohexanones (Fig. 15) [58]. 
 
 
 
Figure 15. Synthesis of pentasubstituted cyclohexanones by Enders et al. 
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3. Cooperative catalysis 
 
 The structural diversity present in the biosynthetic molecules is due to 
the combination of catalytic cascades that involve different enzymes, which 
activate different substrates. For the success of this catalytic combination, it 
is essential the capability of different enzymes to coexist in the same media 
without undesirable interactions. Moreover, some reactions need the 
participation of coenzymes and metallic cofactors as further substrate 
activators. For this reason, the efficient combination of organocatalysts with 
other catalysts, which are able to activate different functional groups, is 
highly desirable to increase the molecular diversity of the synthetic products. 
Cooperative catalysis between organic and metal catalysts has evolved 
rapidly in recent years and its improvement offers to the synthesis of 
enantiomerically pure compounds levels of reactivity, selectivity and 
diversity that are very difficult to get using other methodologies [59].  
 Remarkably, this innovative strategy not only promotes single reactions 
but also enables multiple transformations in a one-pot process for the 
generation of previously unattainable compounds.  
 
4. Conclusion 
 
 Therefore, the design and development of new catalytic strategies is a 
continuing challenge at the forefront of synthetic chemistry. Stereoselective 
organocatalytic reactions have proved to be a powerful tool for the synthesis 
of enantiomerically pure molecules. In addition, catalytic cascade sequences 
allow the minimization of time, cost, effort and waste of synthetic processes, 
thus becoming ideal biomimetic approaches to gain molecular complexity 
efficiently and ecologically. 
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